EZH2 and cancer: Consistent with our findings, Peng et al. [25] showed that in renal cell carcinoma, HOTTIP, by binding to EZH2 and LSD1, epigenetically silenced the expression of LATS2, inhibiting apoptosis and promoting the growth of cancer cells.